Epidermal growth factor and bone morphogenetic proteins upregulate osteoblast proliferation and osteoblastic markers and inhibit bone nodule formation

Archives of Oral Biology

Volumn 55, Issue 9, 2010, Pages 689-701

  Laflamme, Claude ^a   Curt, Sèuerine ^a   Rouabhia, Mahmoud ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Alkaline phosphatase; BMPs egf; Bone nodules; Osteoblasts; Osteocalcin; Runx2

Indexed keywords

EID: 78149358646     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2010.06.010     Document Type: Article

References (50)

1. Salgado AJ, Coutinho OP, Reis RL. Bone tissue engineering: state of the art and future trends. Macromol Biosci 2004; 4(8): 743-65.
2. Geiger M, Li RH, Friess W. Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev 2003; 55(12): 1613-29. (Pubitemid 37420006)
3. Wozney JM, Rosen V, Byrne M, Celeste AJ, Moutsatsos I, Wang EA. Growth factors influencing bone development. J Cell Sci Suppl 1990; 13: 149-56.
4. Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA, et al. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA 1990; 87: 9843-7. (Pubitemid 120016540)
5. Cheng H, JiangW. Phillips FM, Haydon RC, Peng Y, Zhou L, et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 2003; 85: 1544-52. (Pubitemid 36951140)
6. Nakagawa T, Tagawa T. Ultrastructural study of direct bone formation induced by BMPs-collagen complex implanted into an ectopic site. Oral Dis 2000; 6(3): 172-9. (Pubitemid 30340644)
7. Kato M, Toyoda H, Namikawa T, Hoshino M, Terai H, Miyamoto S, et al. Optimized use of a biodegradable polymer as a carrier material for the local delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2). Biomaterials 2006; 27(9): 2035-41. (Pubitemid 41759497)
8. Israel DI, Nove J, Kerns KM, Kaufman RJ, Rosen V, Cox KA, et al. Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. Growth Factors 1996; 13(3-4): 291-300. (Pubitemid 26378947)
9. Onishi T, Ishidou Y, Nagamine T, Yone K, Imamura T, Kato M, et al. Distinct and overlapping patterns of localization of bone morphogenetic protein (BMP) family members and a BMP type II receptor during fracture healing in rats. Bone 1998; 22(6): 605-12. (Pubitemid 28284608)
10. Mont MA, Jones LC, Elias JJ, Inoue N, Yoon TR, Chao EY, et al. Strut-autografting with and without osteogenic protein-1: a preliminary study of a canine femoral head defect model. J Bone Joint Surg Am 2001; 83: 1013-22. (Pubitemid 32662103)
11. Benglis D, Wang MY, Levi AD. A comprehensive review of the safety profile of bone morphogenetic protein in spine surgery. Neurosurgery 2008; 62: 423-31.
12. Govender S, Csimma C, Genant HK, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 2002; 84: 2123-4. (Pubitemid 35417689)
13. Kanakaris NK, Calori GM, Verdonk R, Blokhuis TJ, Cherubino P, De Biase P, et al. Application of BMP-7 to tibial nonunions: a 3-year multicenter experience. Injury 2008; 39: S83-90.
14. Dimitriou R, Dahabreh Z, Katsoulis E, Matthews SJ, Branfoot T, Giannoudis PV. Application of recombinant BMP-7 on persistent upper and lower limb non-unions. Injury 2005; 36: S51-9. (Pubitemid 41608591)
15. Einhorn TA, Majeska RJ, Mohaideen A, Kagel EM, Bouxsein ML, Turek TJ, et al. A single percutaneous injection of recombinant human bone morphogenetic protein-2 accelerates fracture repair. J Bone Joint Surg Am 2003; 85: 1425-35. (Pubitemid 36951125)
16. Smith DM, Cooper GM, Mooney MP, Marra KG, Losee JE. Bone morphogenetic protein 2 therapy for craniofacial surgery. J Craniofac Surg 2008; 19: 1244-59.
17. Kang Q, Sun MH, Cheng H, Peng Y, Montag AG, Deyrup AT, et al. Characterization of the distinct orthotopic boneforming activity of 14 BMPs using recombinant adenovirusmediated gene delivery. Gene Ther 2004; 11: 1312-20. (Pubitemid 39213996)
18. de Jong DS, Vaes BL, Dechering KJ, Feijen A, Hendriks JM, Wehrens R, et al. Identification of novel regulators associated with early-phase osteoblast differentiation. J Bone Miner Res 2004; 19: 947-58. (Pubitemid 41103452)
19. Barnham KJ, Torres AM, Alewood D, Alewood PF, Domagala T, Nice EC, et al. Role of the 6-20 disulfide bridge in the structure and activity of epidermal growth factor. Protein Sci 1998; 7: 1738-49. (Pubitemid 29133178)
20. Shroff B, Kashner JE, Keyser JD, Hebert C, Norris K. Epidermal growth factor and epidermal growth factorreceptor expression in the mouse dental follicle during tooth eruption. Arch Oral Biol 1996; 41(6): 613-7. (Pubitemid 27088215)
21. Tajima Y, Yokose S, Kashimata M, Hiramatsu M, Minami N, Utsumi N. Epidermal growth factor expression in junctional epithelium of rat gingiva. J Periodontal Res 1992; 27: 299-300.
22. Matsuda N, Morita N, Matsuda K, Watanabe M. Proliferation and differentiation of human osteoblastic cells associated with differential activation of MAP kinases in response to epidermal growth factor, in hipoxia and mechanical stress in vitro. Biochem Biophys Res Commun 1998; 249: 350-4. (Pubitemid 28431756)
23. Chien HH, Lin WL, Cho MI. Down-regulation of osteoblastic cell differentiation by epidermal growth factor receptor. Calcif Tissue Int 2000; 67: 141-50.
24. Laflamme C, Rouabhia M. Effect of BMP-2 and BMP-7 homodimers and a mixture of BMP-2/BMP-7 homodimers on osteoblast adhesion and growth following culture on a collagen scaffold. Biomed Mater 2008; 3: 1-10.
25. Thouverey C, Strzelecka-Kiliszek A, Balcerzak M, Buchet R, Pikula S. Matrix vesicles originate from apical membrane microvilli of mineralizing osteoblast-like Saos-2 cells. J Cell Biochem 2009; 106(1): 127-38.
26. Martino CF, Belchenko D, Ferguson V, Nielsen-Preiss S, Qi HJ. The effects of pulsed electromagnetic fields on the cellular activity of SAOS-2 cells. Bioelectromagnetics 2008; 29: 125-32. (Pubitemid 351231237)
27. Kim J, Kim IS, Cho TH, Lee KB, Hwang SJ, Tae G, et al. Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenetic protein-2 and human mesenchymal stem cells. Biomaterials 2007; 28: 1830-7. (Pubitemid 46123539)
28. Jin D, Pei GX, Wang KH, Chen B, Qin Y. The regulatory effect of human bone morphogenetic protein 7 gene transfer on the proliferation and differentiation of rabbit bone marrow mesenchymal stem cells. Zhongguo Yi Xue Ke Xue Bao 2003; 25: 22-5.
29. Bessa PC, Casal M, Reis RL. Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part II (BMP delivery). J Tissue Eng Regen Med 2008; 2: 81-96.
30. Kusumoto K, Parton A, Barnes D. Mitogen limitation and bone morphogenetic protein-4 promote neurogenesis in SFME cells, an EGF-dependent neural stem cell line. In Vitro Cell Dev Biol Anim 2009; 45(1-2): 55-61. Epub. 2008 December 5.
31. DeHaan AM, Wolters NM, Keller ET, Woods Ignatoski KM. EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling. Prostate 2009; 69: 528-37.
32. Zhu J, Jia X, Xiao G, Kang Y, Partridge NC, Qin L. EGF-like ligands stimulate osteoclastogenesis by regulating expression of osteoclast regulatory factors by osteoblasts. J Biol Chem 2007; 282(37): 26656-65.
33. Sibilia M, Kroismayr R, Lichtenberger BM, Natarajan A, Hecking M, Holcmann M. The epidermal growth factor receptor: from development to tumorigenesis. Differentiation 2007; 75: 770-87. (Pubitemid 350086174)
34. Kretzschmar M, Doody J, Massagué J. Opposing BMP and EGF signaling pathways converge on the TGF-β family mediator Smad-1. Nature 1997; 389: 618-22. (Pubitemid 27446181)
35. Semlali A, Jacques E, Plante S, Biardel S, Milot J, Laviolette M, et al. TGF-beta suppresses EGF-induced MAPK signaling and proliferation in asthmatic epithelial cells. Am J Respir Cell Mol Biol 2008; 38(2): 202-8. (Pubitemid 351162842)
36. Gronthos S, Simmons PJ. The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. Blood 1995; 85(4): 929-40.
37. Jiang Y, Vaessen B, Lenvik T, Blackstad M, Reyes M, Verfaille CM. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol 2002; 30: 896-904. (Pubitemid 34845893)
38. McCarty RS, Gronthos S, Zannettino AC, Foster BK, Xian CJ. Characterisation and development potential of ovine bone marrow derived mesenchymal stem cells. J Cell Physiol 2009; 219: 324-33.
39. Handschin AE, Egermann M, Trentz O, Wanner GA, Kock HJ, Zünd G, et al. CBFA-1 (Runx-2) and osteoclacin expression by human osteoblasts in heparin osteoporosis in vitro. Clin Appl Thromb/Hemost 2006; 12(4): 465-72. (Pubitemid 44359245)
40. Yarram SJ, Tasman C, Gidley J, Clare M, Sandy JR, Mansell JP. Epidermal growth factor and calcitriol synergistically induce osteoblast maturation. Mol Cell Endocrinol 2004; 220: 9-20. (Pubitemid 38757877)
41. Elabd C, Chiellini C, Massoudi A, Cochet O, Zaragosi LE, Trojani C, et al. Human adipose tissue-derived multipotent stem cells differentiate in vitro and in vivo into osteocyte-like cells. Biochem Biophys Res Commun 2007; 361: 342-8. (Pubitemid 47193114)
42. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, et al. Targeted disruption of Cbfa1 results in complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997; 89: 755-64. (Pubitemid 27516178)
43. Philipp Seib F, Franke M, Jing D, Werner C, Bornhäuser M. Endogenous bone morphogenetic proteins in human bone marrow-derived multipotent mesenchymal stromal cells. Eur J Cell Biol 2009; 88: 257-71.
44. Omoteyama K, Takagi M. FGF8 regulates myogenesis and induces Runx2 expression and osteoblast differentiation in cultured cells. J Cell Biochem 2009; 106: 546-52.
45. Grasser WA, Orlic I, Borovecki F, Riccardi KA, Simic P, Vukicevic S, et al. BMP-6 exerts its osteoinductive effect through activation of IGF-I and EGF pathways. Int Orthop 2007; 31(6): 759-65. (Pubitemid 350160308)
46. Frank O, Heim M, Jakob M, Barbero A, Chafer D, Bendik I, et al. Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro. J Cell Biochem 2002; 85(4): 737-46. (Pubitemid 34462784)
47. Prince M, Banerjee C, Javed A, Green J, Lian JB, Stein GS, et al. Expression and regulation of Runx2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts. J Cell Biochem 2001; 80(3): 424-40. (Pubitemid 32141498)
48. Kotobuki N, Matsushima A, Kato Y, Kubo Y, Hirose M, Ohgushi H. Small interfering RNA of alkaline phosphatise inhibits matrix mineralization. Cell Tissue Res 2008; 332: 279-88.
49. Antosz ME, Bellows CG, Aubin JE. Biphasic effects of epidermal growth factor on bone nodule formation by isolated rat calvaria cells in vitro. J Bone Miner Res 1987; 2(5) :385-93.
50. Fischer J, Kolk A, Wolfart S, Pautke C, Warnke PH, Plank C, et al. Future of local bone regeneration-protein versus gene therapy. J Craniomaxillofac Surg 2010. doi:10.1016/j.jcms.2010.03.016.